Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Liang

Showing results (131-140 of 1,938) with videos related to

Pageof 194
Sort By:
ACS Medicinal Chemistry Letters|May 20, 2026
Novel Pyrido[4,3‑<i>d</i>]pyrimidine Derivatives as Kirsten Rat Sarcoma (KRAS) G12C Potential InhibitorsRuihu Song, Steven H Liang
Experimental Cell Research|March 1, 1983
Establishment of nucleolar deficient sublines of PtK2 (Potorous tridactylis) by ultraviolet laser microirradiationH Liang, M W Berns
Current Opinion in Rheumatology|July 1, 1995
Assessment outcomes of clinical drug trials in osteoarthritisO Sangha, M H Liang
Current Topics in Microbiology and Immunology|February 26, 2000
Responses of human B cells to DNA and phosphorothioate oligodeoxynucleotidesH Liang, P E Lipsky
ACS Medicinal Chemistry Letters|June 18, 2025
Synthesis and Application of Novel Arginine Vasopressin Receptor 1A (AVPR1A) AntagonistsXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|April 16, 2025
Novel Triazole-Substituted Imidazo[1,2-<i>a</i>]Pyrimidine Compounds as cGAS inhibitorsTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|April 16, 2025
6-Aryl Isoindolin-1-ones: Novel mGluR2 Negative Allosteric ModulatorsYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
Novel 2-Pyrrolidone Derivatives as Negative Allosteric Modulators of GluN2B-Containing NMDA ReceptorsYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|November 19, 2025
Imidazo Pyrimidine Compounds for the Inhibition of Oncogenic KRAS Mutations in Cancer TherapyXiaoyan Li, Steven H Liang
ACS Medicinal Chemistry Letters|September 17, 2025
Novel Cyclic Peptides Trapping Interleukin-1β to Relieve Inflammatory and Atherosclerotic Cardiovascular DiseaseQilong Hu, Steven H Liang
Pageof 194

Showing results (131-140 of 1,938) with videos related to

Sort By:
Pageof 194
ACS Medicinal Chemistry Letters|May 20, 2026
Novel Pyrido[4,3‑<i>d</i>]pyrimidine Derivatives as Kirsten Rat Sarcoma (KRAS) G12C Potential InhibitorsRuihu Song, Steven H Liang
Experimental Cell Research|March 1, 1983
Establishment of nucleolar deficient sublines of PtK2 (Potorous tridactylis) by ultraviolet laser microirradiationH Liang, M W Berns
Current Opinion in Rheumatology|July 1, 1995
Assessment outcomes of clinical drug trials in osteoarthritisO Sangha, M H Liang
Current Topics in Microbiology and Immunology|February 26, 2000
Responses of human B cells to DNA and phosphorothioate oligodeoxynucleotidesH Liang, P E Lipsky
ACS Medicinal Chemistry Letters|June 18, 2025
Synthesis and Application of Novel Arginine Vasopressin Receptor 1A (AVPR1A) AntagonistsXin Zhou, Steven H Liang
ACS Medicinal Chemistry Letters|April 16, 2025
Novel Triazole-Substituted Imidazo[1,2-<i>a</i>]Pyrimidine Compounds as cGAS inhibitorsTaoqian Zhao, Steven H Liang
ACS Medicinal Chemistry Letters|April 16, 2025
6-Aryl Isoindolin-1-ones: Novel mGluR2 Negative Allosteric ModulatorsYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|May 14, 2025
Novel 2-Pyrrolidone Derivatives as Negative Allosteric Modulators of GluN2B-Containing NMDA ReceptorsYinlong Li, Steven H Liang
ACS Medicinal Chemistry Letters|November 19, 2025
Imidazo Pyrimidine Compounds for the Inhibition of Oncogenic KRAS Mutations in Cancer TherapyXiaoyan Li, Steven H Liang
ACS Medicinal Chemistry Letters|September 17, 2025
Novel Cyclic Peptides Trapping Interleukin-1β to Relieve Inflammatory and Atherosclerotic Cardiovascular DiseaseQilong Hu, Steven H Liang
Pageof 194